You are here

Omicron variant

Moderna halts vaccine supply to COVAX in favor of new agreement for omicron-adjusted shots in 2023

Moderna halts vaccine supply to COVAX in favor of new agreement for omicron-adjusted shots in 2023

Fierce Pharma

Moderna Therapeutics

Omicron variant

Flag link:

CDC recommends updated Covid-19 boosters

CDC recommends updated Covid-19 boosters

Stat

Omicron variant

Moderna Therapeutics

Flag link:

FDA authorizes Pfizer and Moderna Covid boosters targeted against Omicron strains

FDA authorizes Pfizer and Moderna Covid boosters targeted against Omicron strains

Stat

Moderna Therapeutics

Omicron variant

Flag link:

Pfizer, Moderna bivalent COVID booster nods could land this week: report

Pfizer, Moderna bivalent COVID booster nods could land this week: report

Fierce Pharma

Moderna Therapeutics

Omicron variant

Flag link:

Pfizer, BioNTech submit omicron booster for FDA clearance

Pfizer, BioNTech submit omicron booster for FDA clearance

BioPharma Dive

Omicron variant

Flag link:

Moderna to supply 12 mln doses of Omicron-targeted COVID shot to Canada

Moderna to supply 12 mln doses of Omicron-targeted COVID shot to Canada

Yahoo/Reuters

Moderna Therapeutics

Omicron variant

Flag link:

UK becomes first country to approve updated Moderna vaccine targeting omicron

UK becomes first country to approve updated Moderna vaccine targeting omicron

The Hill

Moderna Therapeutics

Omicron variant

Flag link:

BioNTech expects Omicron-adapted vaccine deliveries as soon as October

BioNTech expects Omicron-adapted vaccine deliveries as soon as October

Yahoo/Reuters

Omicron variant

Flag link:

US reaches deal with Moderna for omicron COVID-19 vaccine

US reaches deal with Moderna for omicron COVID-19 vaccine

The Hill

Omicron variant

government contracts

Flag link:

Reformulated COVID vaccine boosters may be available earlier than expected

Reformulated COVID vaccine boosters may be available earlier than expected

NPR

Omicron variant

Flag link:

COVID-19 vaccines and omicron: 2 new findings

COVID-19 vaccines and omicron: 2 new findings

Beckers Hospital Review

Omicron variant

Flag link:

Study shows AstraZeneca's Covid-19 mAb Evusheld may not work against dominant Omicron strain

Study shows AstraZeneca's Covid-19 mAb Evusheld may not work against dominant Omicron strain

Endpoints

Omicron variant

Flag link:

FDA panel recommends altered COVID-19 vaccines to target omicron subvariants

FDA panel recommends altered COVID-19 vaccines to target omicron subvariants

Beckers Hospital Review

Omicron variant

Flag link:

Pfizer joins the omicron data party, linking adapted vaccine to increased immune response ahead of FDA meeting

Pfizer joins the omicron data party, linking adapted vaccine to increased immune response ahead of FDA meeting

Fierce Biotech

Omicron variant

Flag link:

Pfizer’s Covid Vaccine Protection Against Omicron Fades Just Weeks After Second And Third Doses, Study Finds

Pfizer’s Covid Vaccine Protection Against Omicron Fades Just Weeks After Second And Third Doses, Study Finds

Forbes

Omicron variant

Flag link:

AstraZeneca antibody drug effective against BA.2, study finds

AstraZeneca antibody drug effective against BA.2, study finds

Beckers Hospital Review

Omicron variant

Flag link:

Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Bivalent Booster Candidate

Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Bivalent Booster Candidate

Yahoo/Accesswire

Moderna Therapeutics

clinical trials

Omicron variant

bivalent boosters

Flag link:

Early data indicate vaccines still protect against Omicron’s sister variant, BA.2

Early data indicate vaccines still protect against Omicron’s sister variant, BA.2

Stat

Omicron variant

Flag link: